Millipore adds water purification system for ion chromatography
The system improves baseline stability and reduces downtime in Dionex IC equipment.
Millipore of Billerica, MA, US, says ultrapure water from the ICW-3000 system increases the precision of IC analyses.
The ICW-3000 system provides a continual flow of ultrapure water to the eluent generator and regenerant lines of the suppressor. This reduces the carbonate content in the water - sharply decreasing contamination risks and improving experiment reproducibility, while also removing the need for helium. The water system also eliminates the need for eluent preparation and the instrument downtime that occurs when filling eluent bottles.
With only two tubes and one power cord to connect, the system simple to install. Everyday use is also easy. The user just fills the system's 10-litre tank with pure water in order to produce a constant flow of ultrapure water for the IC system. The ICW-3000 system is remote-controlled by the Dionex IC system and both systems are fully compatible.
You may also like
Trending Articles
You may also like
Analysis
Cochrane review links pharma payments to prescribing practices
A Cochrane review of 93 studies has linked pharmaceutical industry promotional activities with less appropriate prescribing and higher prescription costs, prompting renewed calls for stronger conflict-of-interest policies and greater transparency in the UK
Manufacturing
Patented device reinvents Solid Phase Extraction
Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Media
CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges
The two-day programme addresses practical barriers to sustainable procurement, manufacturing and packaging — with hackathon-style sessions and cross-industry collaboration designed to move beyond targets into measurable operational action
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility
The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life